The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide.

The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during ...

Patients with left main coronary artery disease had similar 10-year mortality after PCI or CABG, according to new data. Read ...

Percutaneous coronary intervention (PCI) has proven lifesaving: Morbidity and mortality outcomes are significantly improved with PCI when compared to clot-busting therapy. However, not all hospitals ...

Technique to prep calcified plaque produces good results on imaging ...

When dual antiplatelet therapy was stopped 12 months after PCI, clopidogrel monotherapy lowered cardiovascular and bleeding ...

Facilitated percutaneous coronary intervention (PCI) refers to using fibrinolytic therapy to stabilize the patient while transport is being arranged to a primary PCI facility. This strategy receives a ...

Age-related physiological changes augment both the potential benefit of coronary revascularization and the risk of procedure-related adverse outcomes A broad range of antithrombin and antiplatelet ...

Percutaneous coronary intervention (PCI) rates held steady after a COURAGE trial-related dip but have increasingly moved to the outpatient setting, population-based data from several states showed.

Results from the first randomized trial of Impella pumps during complex stent procedures, published in the New England ...